source
- Former Orbital scientists launch new mRNA therapy startupTwo scientists think they've solved a technical problem that has kept the mRNA revolution from reaching its full potential. Now, they're launching ParcelBio with $13 million in seed funding to deve…Endpoints · 2mo ago↗ source
- Avalo scores Phase 2 success in comeback bid, raises $375MAvalo Therapeutics’ comeback bid surged forward Tuesday afternoon, as the immunology biotech secured a mid-stage trial win in an inflammatory skin disorder. Avalo said that both doses of an experim…Endpoints · 2mo ago↗ source
- STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseaseAn international team has found thousands of mini-proteins, including some involved in cell division and DNA repair, as well as several unique to cancer cells.